Key Facts

In the United States

  • Location: Swiftwater, PA
  • Revenue: $2.64 billion in 2011.
  • Employees: 3,000 employees

A global company:

  • Headquarters: Lyon, France
  • Revenue: €3,897 million in 2012 (growth of 5.7% compared with 2011 at constant exchange rates)
  • Nearly 13,000 employees worldwide
  • More than 50% of staff devoted to industrial operations
  • 15 Production and/or R&D sites - 13 operational:
    • Marcy l'Etoile and Val de Reuil (FRANCE)
    • Swiftwater (Pennsylvania)
    • Cambridge and Canton (Massachusetts)
    • Orlando (Florida)
    • Rockville (Maryland) (USA)
    • Toronto (CANADA)
    • Pilar (ARGENTINA)
    • Shenzhen (CHINA)
    • Hyderabad (INDIA)
    • Ocoyoacac (MEXICO)
    • Chachoengsao (THAILAND)
  • 2 new facilities under construction:
    • Neuville (FRANCE)
    • Shenzhen (CHINA)

Investment in research and production capacity:

  • More than one billion doses of vaccines produced yearly to immunize more than 500 million people in the world
  • Largest product range available, against 20 infectious diseases
  • More than €1 million invested every day in R&D
  • Nearly €2 billion invested in the last 5 years in production infrastructures.